Form EFFECT Estrella Immunopharma,

January 26, 2026 6:04 AM UTC
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 23, 2026 4:00 P.M.
Form: S-1
CIK: 0001844417
Company Name: Estrella Immunopharma, Inc.
File Number: 333-292331


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings